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The year 2003 marks the 50th anniversary of the original
demonstration by Edler and Hertz (1) of the feasibility of
recording cardiac structure and function using pulsed re-
flected ultrasound. From this unheralded beginning, echo-
cardiography has grown to become the most widely used
cardiac imaging technique in the world with over 20 million
studies per year currently performed in the U.S. alone. The
growth in echocardiography on both the clinical and re-
search fronts has been exponential. In the last year alone,
one can identify more papers using the search term “echo-
cardiography” than in the first 25 years after Elder’s initial
description combined.
Progress in echocardiography has come largely through:
1) the introduction and validation of new technology, 2)
refinement or extension of existing diagnostic methods, and
3) application of new and established methods to areas of
current clinical focus. This review examines the advances in
each of these areas during the past year. Because of the
enormous number of publications dealing with echocardi-
ography, it is impossible to be encyclopedic, but an attempt
is made to highlight important areas, to place recent
advances in some perspective, and to indicate the potential
and limitations of these methods.
VALIDATION OF NEW TECHNOLOGY
Although the fundamental echocardiographic techniques—
M-mode and two-dimensional imaging, spectral and color
flow Doppler, and their combinations—for transesophageal
and intravascular diagnosis have been established for many
years, relatively new modifications of these technologies
have recently been described or are undergoing continued
clinical evaluation. These new approaches include: 1) tissue
Doppler imaging (TDI), 2) strain rate and strain analysis,
and 3) “real-time” three-dimensional (RT3D) imaging.
DTI. Doppler tissue imaging uses the pulsed Doppler
technique (modified to record low velocity, high amplitude
signals from tissue) to record the velocity and timing of
myocardial motion. Because Doppler velocities are angle-
dependent, most studies report velocities from myocardium
moving directly toward or away from the transducer (e.g.,
radial velocities from the parasternal window or longitudinal
velocities from any point in the left ventricle [LV] from the
apical window). Longitudinal velocities are most commonly
reported and may be described for individual segments (e.g.,
motion of the annulus toward the apex) or as an average of
multiple segment velocities. Peak myocardial velocities dur-
ing systole (Sm) and during diastolic rapid filling (Em) or
following atrial contraction (Am) have been reported to be
useful for quantifying global and regional myocardial sys-
tolic and diastolic LV function (2–4) and to correlate with
prognosis in patients with a variety of cardiovascular dis-
eases (5). Recent studies have also reported that decreased
velocities in experimental models and patients with hyper-
trophic cardiomyopathy mutations but without hypertrophy
are predictive of the development of the hypertrophic
cardiomyopathy phenotype (6–8). Reduced myocardial
function by TDI has also been demonstrated before the
development of hypertrophy in Fabry disease patients with
normal ejection fractions (9).
Although the Sm correlates reasonably well with mea-
sures of global LV function, it appears limited by both
preload and afterload dependence (10). Recent reports
suggest that myocardial acceleration during isovolumic con-
traction acceleration (IVA) (calculated as the difference
between baseline and peak velocity during isovolumic con-
traction divided by the time interval) is a robust measure of
both right ventricle and LV contractile function that is
unaffected by large changes in preload and afterload (10,11).
Myocardial acceleration during isovolumic contraction was
also able to describe the force-frequency relationship
(changes in contractility with changing heart rate) (10); IVA
correlated closely with dp/dtmax as heart rate increased from
120 to 160 beats/min (r2  0.92). However, over the same
range, there was no change in peak elastance (Emax). Thus,
while the identification of an ideal measure of LV contrac-
tile function independent of preload and afterload has been
elusive, these data raise the possibility that IVA may be such
an index that can be obtained noninvasively. Additional
studies will be necessary to validate these results in the
clinical environment in normal and diseased ventricles.
Several recent experimental and clinical studies have also
expanded our understanding of the role of TDI in the
assessment of diastolic function. Measurement of early
(Em) and late (Am) diastolic myocardial velocities along the
long axis of the LV at the level of the mitral annulus have
been shown to be useful for determining LV relaxation and
filling pressure; however, the peak myocardial velocity (Em)
is load-dependent in normal subjects. In an experimental
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study, Hasegawa and colleagues (12) showed that the
normal LV expands symmetrically during rapid early filling
and that peak longitudinal expansion, like radial expansion,
occurs coincident with the peak E wave and cross-over of
the left atrium-LV pressure gradient (12). However, after
pacing-induced heart failure, this synchrony of relaxation
was altered, and longitudinal expansion was delayed, occur-
ring after the crossover of left atrium-LV pressure, and was
relatively independent of left atrium pressure because Em
occurred after the left atrium-LV gradient had reversed.
Although the authors observed a very good correlation
between Em and tau (r2  0.85), the best correlation was
between the time from the peak of the E-wave (peak
transmitral flow velocity) to the peak of the Em-wave
(TEm-E ms) and tau (r
2  0.97). Similarly, in a combined
experimental and clinical study, it was reported that IVC
occlusion resulted in a significant decrease in Em before, but
not after, circumflex ligation, whereas its effect on the time
interval (TEm-E) was minimal under both circumstances
(13), supporting the relative preload independence of the
time interval. Clinical studies confirmed the relationship of
TEm-E to tau (tau  32  0.7 TEm-E, r  0.83), its ability
to distinguish normal from pseudonormal inflow patterns,
and its potential use in predicting pulmonary capillary
wedge pressure. Unfortunately, the actual time intervals
measured were very small (40 ms), several measurements
are required, each with its own inherent errors, and subjects
with mitral valve disease were excluded, so that the ulti-
mately clinical utility remains to be determined.
Tissue Doppler has also been proposed as an attractive
technique for quantifying segmental function during stress
echoes because TDI: 1) compares well with reference
methods such as sonomicrometry, 2) permits sensitive
assessment of segmental myocardial function, and 3) is
sensitive to inotropic stimulation and ischemic challenge
(14). In diabetic patients with normal ejection fractions
studied before and during dobutamine stress echocardiog-
raphy (DSE), Fang et al. (15) reported that at baseline both
Sm and Em were reduced compared with controls. How-
ever, with inotropic stimulation, both indexes augmented
normally, suggesting that TDI may detect microvascular or
tissue structural changes before the development of abnor-
malities in the standard measures of systolic function or loss
of inotropic response (15).
Strain and strain rate imaging (SRI). Strain rate imaging
is a recently described modification of TDI that provides a
quantitative measure of regional myocardial function (16).
Strain rate is defined as the difference in myocardial veloc-
ities (as defined by TDI) between two axial points (usually
separated by 1 cm) along the path of the echocardiographic
beam per unit time (17). Strain is the integral of strain rate
over time, and these measures represent the instantaneous
and total deformation of the myocardium within the sam-
pled region. Strain rate and strain appear to be relatively
load-independent quantitative measures of function, and
can potentially be determined for different layers of the
myocardium (18). Although derived from tissue velocities,
these measures are relatively unaffected by translation and
tethering and, thus, have been suggested to be more specific
than TDI alone.
Strain rate and strain have been proposed as useful
quantitative measures of myocardial function in ischemia,
particularly during stress echocardiography. In a study
performed during DSE, the ratio of post-systolic to peak
strain was demonstrated to yield the best sensitivity and
specificity for detecting ischemic segments. Unfortunately,
the incremental increase in sensitivity and specificity over
visual assessment of wall motion was small (81% to 82% and
86% to 89%, respectively) (19). The ability of strain rate and
strain to differentiate nontransmural from transmural in-
farction during dobutamine stress was also demonstrated in
an experimental study (20).
Strain rate and strain have also been reported to detect
changes in baseline function in a variety of conditions before
abnormalities in conventional measure of performance such
as the ejection fraction. In patients with amyloidosis TDI,
strain rate and strain were compared for the detection of
early dysfunction before the development of congestive
heart failure. Mean strain rate and strain, but not TDI, were
both significantly different in amyloid patients with and
without congestive heart failure from the controls (21).
Strain and strain rate measurements also demonstrated
improvement in function in patients with Fabry’s disease
after 12 months of enzyme replacement therapy (22). In
patients with hypertension and preserved systolic function,
it was demonstrated that strain rate and strain were lower
than in controls (23). These studies support the concept that
strain rate and strain may be abnormal even when ejection
fraction and fractional shortening are normal and, hence, are
earlier markers of myocardial dysfunction than conventional
measures. At present, however, these measurements of
strain rate and strain are angle-dependent, the data can be
quite noisy, and significant expertise is required to identify
appropriate recordings for analysis.
Three-dimensional echocardiography. The evolution of
parallel processing techniques that permit multiple, b-mode
data lines to be acquired for each transmitted pulse and
matrix array transducers that allow the beam to be flexibly
directed within a three-dimensional volume have permitted
the direct acquisition of a true RT3D data set. The
advantages of RT3D imaging are that acquisition is faster,
data is acquired in a spatially correct orientation without the
need for electrocardiogram or respiratory gating, and the
images are immediately available for analysis. In addition,
orthogonal planes can be recorded simultaneously with full
two-dimensional image resolution (24). Validation studies
have confirmed that, like earlier three-dimensional recon-
struction approaches, RT3D is superior to standard two-
dimensional methods in the determination of LV volume,
mass, perfusion territory defined by myocardial contrast
echocardiography (MCE), and right ventricle volumes (25–
27). Unfortunately, despite parallel processing, the line
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density in the three-dimensional volume is less than in a
two-dimensional image requiring more interpolation be-
tween data points; the beam may not be optimally aligned to
record all structures within the imaged volume reducing
image quality; and the “frame rate” is slower than conven-
tional two-dimensional imaging. Despite these limitations,
the more rapid acquisition time and immediacy of data
availability will undoubtedly make RT3D imaging the
method of choice for most clinical applications.
The role of three-dimensional echocardiography in clin-
ical practice continues to evolve. Three-dimensional echo-
cardiography has proven useful for the guidance of inter-
ventional and surgical procedures. Imaging of the interatrial
septum during closure of atrial septal defects was reported
by Miller et al. (28) and Acar et al. (29) and appeared
preferable to transesophageal echocardiography guidance.
Suematsu et al. (30) used three-dimensional echocardiog-
raphy to monitor robotic atrial septal defect closure in
experimental models and reported excellent correlation with
directly measured defect size. Three-dimensional guided
electrode placement for atrial pacing was also described by
Szili-Torok et al. (31).
Three-dimensional color-Doppler imaging is a natural
extension of three-dimensional echocardiography with im-
proved visual evaluation of regurgitant jet morphology and
location reported (32). Color-tissue Doppler was also ex-
tended to three-dimensional by mapping velocity, strain,
and strain rate data from two-dimensional images onto
three-dimensional surfaces derived from three standard
two-dimensional apical views (33).
The task of simplifying acquisition and segmentation for
ventricular and atrial volume and LV mass measurement
remains essential for routine clinical application of three-
dimensional echocardiography. Several freehand three-
dimensional echocardiography studies were reported: Dor-
osz et al. (34) described a three-dimensional-guided, two-
dimensional imaging method using a freehand transducer to
improve the accuracy of imaging plane selection for mea-
suring right ventricle volumes. Three-dimensional freehand
scanning for LV volume and ejection fraction calculations
were also validated by Mannaerts et al. (35) with magnetic
resonance imaging and Kawai et al. (36) with gated scin-
tigraphy. Wong et al. (37) report on a novel catalog-based
method for quantifying LV volume from a limited number
of traced points. Handke et al. (38) also studied aortic valve
geometry and motion using a new, high-frame rate system
for three-dimensional echocardiography based on direct
acquisition of the radiofrequency signal. Thus, the potential
applications for three-dimensional echocardiography imag-
ing continue to increase. Improvements in transducer tech-
nology and processing speed for RT3D image acquisition in
conjunction with real-time volume rendering should make it
possible to integrate three-dimensional imaging into the
routine clinical examination of selected patients.
REFINEMENTS AND
ADVANCES IN EXISTING TECHNOLOGIES
Tissue characterization. Ultrasonic tissue characterization
is based on quantitation of the backscattered signals arising
from within the myocardium. Alteration in tissue properties
due to edema, fibrosis, and calcification have been demon-
strated in experimental and human studies to alter ultrasonic
backscatter (39). A number of measures of backscatter have
been reported including: 1) the mean integrate backscatter
(IB) (backscatter averaged over the cardiac cycle) and often
expressed as the ratio of IB in the region of interest to some
reference area within the image (e.g., the blood pool) to
correct for attenuation, or 2) cyclic variation in integrated
backscatter CVIB (measured as the difference between the
nadir and peak of the IB signal during the cardiac cycle).
Cyclic variation in IB has been suggested to be more
sensitive than standard measures of cardiac function in
certain settings and does not require calibration for attenu-
ative losses. Integrated backscatter, in contrast, has been
most closely correlated with tissue collagen content.
Changes in IB have been reported to occur in a variety of
pathologies including ischemia and infarction, cardiomyop-
athy, atherosclerosis, and transplant rejection. In the past
year, IB has been reported to provide unique information in
a variety of pathologies including Duchenne muscular dys-
trophy (40), essential hypertension, acute myocardial infarc-
tion with spontaneous reperfusion, and congenital aortic
stenosis (41). In children with Duchenne muscular dystro-
phy, IB has been reported to identify early changes in
myocardial structure (cyclic variation in IB decreased and
mean calibrated IB increased) before the development of
overt cardiomyopathy or expected collagen increase (40).
Cyclic variation in IB has also been shown to correlate with
LV mass in patients with essential hypertension but to
predict changes in function before changes in fractional
shortening (42). Changes similar to those seen with hyper-
trophy were reported in diabetics that were independent and
incremental to the effects of LV hypertrophy (15). In
patients with acute anterior wall infarcts, phase-corrected
cyclic variation in IB was found to predict spontaneous
reperfusion with a sensitivity of 96% and specificity of 90%
(43). While IB can often differentiate between normal and
disease states, absolute values for IB are not disease-specific.
In addition, because IB is angle-dependent, only signals
from structures that are perpendicular to the path of the
ultrasound beam are usually analyzed.
MCE. Recent advances in MCE have focused on the
development of new, more stable contrast agents with shell
properties that permit interaction with the endothelium, the
use of targeted bubble destruction for the local delivery of
adenoviral or plasmid DNA (44), and the clinical validation
of MCE after intravenous contrast injection to reliably
assess myocardial perfusion and predict recovery of function
after mechanical restoration of coronary flow.
Ultrasound microbubbles targeted to the leukocyte adhe-
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sion molecule ICAM-1 by conjugation with anti-ICAM-1
antibody have been shown to preferentially bind to inflam-
matory, cultured human endothelial cells. Microbubble
adhesion has been shown to relate to surface antibody
concentration and shear rates (45). More recently, targeted
contrast uptake was shown to increase in an in vivo model of
transplant rejection (46). Another agent that consists of a
perfluorobutane bubble stabilized by a phospholipid mono-
layer was shown in experimental studies to accumulate in
the myocardium with the result that 15 min after injection
the concentration in the myocardium was 2.1 times that in
the LV cavity. In addition, during coronary reperfusion the
contrast intensity in the risk area was paradoxically in-
creased, creating a “bright spot” despite reduced perfusion
(47). If validated in clinical studies, the potential of these
specially designed bubbles to enhance diagnosis and aug-
ment drug and gene delivery is enormous.
Clinical studies have focused on the ability of intravenous
MCE to detect myocardial ischemia and predict recovery of
function after interventional procedures. In a multicenter
trial, MCE was compared with single photon emission
computed tomography during dipyridamole stress testing
for the detection of ischemia. Good correlation was found,
and after correcting the single photon emission computed
tomography data for angiographic lesions, examples were
presented in which MCE was more reliable. This study was
limited by low enrollment, with only 43 patients available
for study and catheterization in only 15 (48). The ability of
MCE to predict recovery of function after coronary inter-
vention was examined in several studies. In patients with
acute myocardial infarction treated by stenting, MCE pre-
dicted recovery with a sensitivity of 88% and specificity of
74% (49). Myocardial contrast echocardiography was also
compared with DSE and rest-redistribution TI 201 tomog-
raphy for the prediction of recovery of function after
coronary artery bypass grafting. Studies performed before
coronary artery bypass grafting were compared with recov-
ery of function three to four months after surgery. The
product of peak myocardial contrast intensity   was the
best parameter for predicting recovery of function, had a
similar sensitivity to, but higher specificity than, TI 201, and
improved the accuracy of DSE in predicting recovery of
function. However, qualitative MCE was feasible in only
80% of segments, whereas quantitative MCE was feasible in
only 74%, highlighting a potential limitation of MCE (50).
Myocardial contrast echocardiography was also reported to
be superior to ST-segment resolution on the 180 min
electrocardiogram, corrected Thrombolysis in Myocardial
Infarction frame count, and myocardial blush grade in
predicting wall motion score index within the risk area at
four weeks (51). These clinical studies, although largely
confirmatory and limited by small numbers, lend continued
support to the potential application of MCE in patients
with ischemic heart disease.
Stress echocardiography. Despite the proven accuracy of
DSE, its sensitivity and specificity are imperfect (particu-
larly in single-vessel disease) and may be affected by diffi-
culties in appreciating subtle wall motion abnormalities at
peak stress in the tachycardiac, hyperdynamic LV (52).
Mathias et al. (53) report that metoprolol injected (5 mg
intravenous) immediately after acquisition of peak stress
images raised the sensitivity of DSE, especially in patients
with single-vessel coronary artery disease, without a signif-
icant loss of specificity.
Recent clinical stress echocardiography studies have pri-
marily centered on the evaluation of prognosis in large
populations with acute and chronic coronary artery disease
and have confirmed that dipyridamole or DSE are effective
in predicting cardiac death during long-term follow-up
(54,55), that a negative test is associated with a favorable
outcome (54), and that the location (anterior wall) of
ischemia is predictive of increased risk of cardiac death and
nonfatal myocardial infarction independent of the extent of
abnormal wall motion (56). In addition, it has been dem-
onstrated that a biphasic response (improvement at low
stress followed by deterioration with increased stimulation)
can be seen with exercise as well as dobutamine stress in
patients early after acute myocardial infarction and is an
accurate tool for detecting infarct-artery-related stenosis
and predicting functional recovery (57). Interestingly, in
patients with suspected coronary artery disease (based on
suspected angina equivalent [dyspnea or palpitations], mul-
tiple risk factors, or the desire to exclude coronary artery
disease because of occupation [total n 1,859]) but without
classic angina, exercise echocardiography added no addi-
tional prognostic information beyond that provided by a
standard exercise test and resting echocardiogram (58).
APPLICATION OF NEW
AND ESTABLISHED TECHNOLOGIES
TO AREAS OF CURRENT CLINICAL FOCUS
Cardiac resynchronization therapy (CRT). Recent con-
trolled clinical trials have demonstrated both acute hemo-
dynamic and long-term functional benefit from CRT with
biventricular pacing in a subgroup of patients (comprising
60% to 70%) with class III/IV heart failure and left bundle
branch block (59–61). Because CRT is complex and ex-
pensive, identification of patients most likely to benefit is
important. Several recent studies suggest that the direct
assessment of the degree and timing of dyssynchronous wall
motion by a variety of echocardiography methods including
M-mode echocardiography, Fourier analysis of phasic
change in two-dimensional recordings (61), tissue Doppler,
strain rate, and strain recordings may better identify patients
more likely to benefit from CRT than the surface electro-
cardiogram (61–63).
Longer term results were reported by St. John Sutton and
colleagues (64) who analyzed LV volumes, ejection fraction,
mass, degree of mitral regurgitation, LV filling time, and
performance index at baseline and after three and six
months of CRT in 323 patients from the Multicenter
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InSync Randomized Clinical Evaluation (MIRACLE) trial.
Significant reductions in LV volumes occurred at three
months and continued from three to six months in the CRT
group but not in controls. There was also a small, but
significant, increase is ejection fraction at six months (3.6%
vs. 0.4% p  0.01). Mitral regurgitation jet area and LV
mass also declined, but LV shape did not change. Changes
in LV end-diastolic volume and ejection fraction from
baseline to six months were significantly greater (twofold) in
patients with nonischemic LV dysfunction than in patients
with equivalent LV dysfunction due to ischemic heart
disease. Importantly, changes in LV end-diastolic volume
and ejection fraction in the CRT group were independent of
B-adrenergic blockade (64).
Although global measures of LV performance clearly
improve in most patients after CRT, the assessment of
regional performance is more complex. In the presence of
asynchrony, there is regional redistribution of myocardial
fiber strain with associated changes in regional blood flow
and metabolism (65). In a study by Breithardt et al. (66),
early systolic septal shortening was often accompanied by
lateral wall lengthening. Late activation of these stretched
lateral wall segments was associated with higher peak
negative strain rate and wall stress. Cardiac resynchroniza-
tion therapy led to redistribution of longitudinal myocardial
deformation with the majority of patients being well syn-
chronized or “oversynchronized” (i.e., the lateral wall short-
ened before the septum) (66). Although in theory restora-
tion of synchrony in myocardial strain should increase
energy efficiency and result in favorable global remodeling,
further studies are necessary to confirm these effects.
The presence of functional mitral regurgitation in heart
failure appears to be strongly dependent on alterations in
LV shape, as the tethering forces that act on the mitral
leaflets are higher in dilated, more spherical ventricles
(67–69). In an elegant study, it was shown that CRT caused
an increase in the peak closing force as well as an increase in
LV  dp/dtmax during isovolumic contraction (70). These
changes effectively counteracted the increased tethering
forces that impair mitral leaflet closure and decreased the
effective regurgitant orifice area. Although the changes in
functional mitral regurgitation produced by CRT in this
acute study occurred in the absence of reverse remodeling,
this phenomenon could further reduce functional mitral
regurgitation during chronic therapy.
Coronary arteries. Recent studies support the ability of
transthoracic Doppler recordings to detect restenosis in the
left anterior descending coronary artery after coronary an-
gioplasty based on a ratio of baseline to hyperemic coronary
flow 2 (sensitivity 89%, specificity 90%) (71). When
compared with abnormal wall motion by DSE for the
detection of left anterior descending coronary stenoses,
coronary flow velocity reserve (CFVR) 2 had a sensitivity
of 75% and a specificity of 79% versus 78% and 89%,
respectively, for DSE (72). These methods have now been
extended to include the posterior descending coronary artery
and applied to children with Kawasaki disease (73). In
Kawasaki patients, peak and mean CFVR were lower in
those with significant angiographic stenosis with a CFVR of
2.0, predicting significant coronary stenosis with a sensi-
tivity of 89% and a specificity of 96%. In adults, recording
the posterior descending artery has proven more difficult but
can be improved with contrast injection (80%) (74).
Success rates are higher with right dominant and balanced
circulations, and correlations with Doppler flow wire mea-
surements have been good (r  0.85). Despite these
promising results, noninvasive recording of coronary flow is
technically demanding, and the absence of flow is difficult to
interpret. The role of this technique relative to other
methods for detecting ischemia remains to be defined.
Left atrium. Interest in the left atrium has been stimulated
by the recent clinical focus on treatment of atrial fibrillation,
the relationship of atrial fibrillation and left atrial enlarge-
ment to embolic stroke, and the value of left atrial volume
(LAV) as a predictor of diastolic dysfunction.
Recent studies have examined the relationship of echo-
cardiographically defined left atrium volume to clinical
outcomes in a variety of clinical situations. In a study
designed to examine whether subclinical abnormalities de-
tected by echocardiography are predictive of first age-related
cardiovascular events in an elderly population, LAV was
found to be independently predictive in a multivariate
model containing age, diabetes, gender, systemic hyperten-
sion, LV systolic function, LV diastolic function, and LV
mass. In contrast, presenting symptoms (chest pain, dys-
pnea, lightheadedness, palpitations, presyncope, syncope)
leading to echocardiographic referral were not indepen-
dently predictive in univariate or multivariate models. Al-
though the other components of the model have previously
been shown to predict risk, the contribution of left atrium
volume to risk has not been widely appreciated (75).
In a study of patients with acute myocardial infarction,
the LAV index (LAV/body surface area [BSA]) was a
predictor of mortality even after adjustment for conven-
tional indexes of systolic and diastolic function (76). These
observations are in agreement with prior data that LV
ejection fraction is not an independent predictor of outcome
in acute myocardial infarction when assessment of diastolic
function is available (77,78). The additional valve of LAV/
BSA to standard assessments of diastolic function is attrib-
uted to the relationship of LAV to the duration and severity
of elevated LV filling pressures as opposed to Doppler
indexes that are preload-dependent and reflect instanta-
neous change in the transmitral gradient.
Pulmonary embolism. Small series have described the
prevalence, natural history, and prognostic significance of
right heart thrombi in patients with pulmonary embolism.
In a series of 1,113 patients from the international cooper-
ative pulmonary embolism registry, Torbicki et al. (79)
reported that 4% of patients with pulmonary embolism had
right heart thrombi. This group had a shorter duration of
symptoms, lower systolic blood pressure, and more frequent
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right ventricular hypokinesis and congestive heart failure
than patients with pulmonary embolism but without right
heart thrombi. The overall mortality at two weeks and three
month was higher for the group with right heart thrombi
(21% vs. 11% and 29% vs. 16%, respectively) with the
differences in mortality in the right heart thrombi group
being almost entirely in the subgroup treated with heparin
despite similar clinical severity at presentation.
Valvular heart disease/hemodynamics. VALVULAR STE-
NOSIS. The stenotic valve area is usually measured at
catheterization using the Gorlin formula or by echocardi-
ography using the continuity equation. However, there are
often discrepancies in these measures that are attributed to
the effects of pressure recovery. Pressure recovery occurs
when the streamlines of flow passing through an area of
stenosis reexpand and reattach to the vessel wall with the
result that kinetic energy is converted back to pressure
energy (80,81). Conversely, the pressure loss distal to a
stenosis is due to the turbulence that occurs when the high
velocity jet encounters stagnant fluid within the aortic sinus
as it seeks to expand. It is the turbulence at this boundary
that dissipates energy (i.e., kinetic energy is lost as heat) and
limits pressure recovery. The smaller the aorta, the less the
opportunity for the development of turbulence, and, hence,
the greater the pressure recovered. Therefore, the magni-
tude of the recovered pressure relates to ratio of effective
orifice area to the ascending aortic area. Doppler measures
of aortic valve area rely on the peak velocity or gradient
measured across the aortic valve and reflect the true effective
orifice area, while catheterization measures that use the
pressure gradient after pressure recovery (the net pressure
loss) will yield larger values for effective orifice area. Al-
though the effective orifice area cath is a less accurate
measure of the physiologic effective orifice area, it appears to
be a better measure of outcomes because is it derived from
the true energy loss to the system. Several recent studies
have suggested methods for correcting the Doppler effective
orifice area for the effects of pressure recovery. They propose
an “energy loss coefficient” that adjusts the Doppler effective
orifice area for factors that determine the energy loss across
the valve in which the Doppler effective orifice area is
multiplied by Aa/(Aa EOA)  1  (EOA/(Aa EOA),
where Aa is the area at the sinotubular junction and EOA
is effective orifice area (82). As might be expected, the
greatest discrepancies occur in patients with the smallest
aortas where pressure recovery is the greatest. Understand-
ing this relationship is important, particularly in the evalu-
ation of patients whose areas are at the border of severity
grade. Whether actual correction is necessary is unclear
because, although the percent difference may be significant,
the absolute differences are small, particularly when viewed
in the context of the standard error of these measurements
(in most studies 0.2 cm2). However, these studies empha-
size the importance of aortic dilation because, for a constant
valve area, dilation of the aorta, by itself, can significantly
decrease pressure recovery and, hence, independently in-
crease the effect of a stenosis (82,83). In another study, it
was shown that a measure of stroke work loss (SWL)
defined as SWL  100  P/(P  SPB) was the most
clinically efficient Doppler measure (when compared with
Vmax, P, or aortic valve resistance) in terms of predicting
symptomatic status and outcome (84). Here again, although
the differences were not great, it appears that measures that
emphasize the loss of energy are the most appropriate for
determining clinical relevance. Importantly, these discus-
sions reemphasize the fact that the Doppler-derived aortic
valve areas are generally smaller than those reported at
catheterization and may lead to misclassification of severity
using current catheter-based recommendations, They also
remind us that the impact of aortic stenosis on the LV is due
to energy loss or wastage rather than a simple measure of
gradient or area, and that the size of the aorta and the inlet
geometry of the valve (85) are important determinants of
energy loss independent of valve area.
VALVULAR REGURGITATION. Ischemic mitral regurgitation
has been shown to be due to displacement of the papillary
muscles, which increases the tension on the mitral leaflets
displacing them away from the annulus and increasing the
leaflet area necessary to completely occlude the annulus.
This effect is augmented by annular dilation and modified
by leaflet length. Because of the geometry of the chordal
insertions, the maximal tension is exerted by the basal or
intermediate chords, which attach to the midportion of the
anterior leaflet. Recent experimental studies have suggested
that transection of the central basal chords could reduce the
severity of mitral regurgitation without causing prolapse. In
a report by Messas et al. (86), these observations were
extended to the chronic model where it was shown that
cutting a minimal number of basal chords decreased regur-
gitation without causing prolapse or adversely effecting LV
function. Using an alternative approach, Hung et al. (87)
demonstrated that reversing ventricular remodeling using an
externally positioned inflatable device returned the papillary
muscles to a more normal position and reduced the severity
of mitral regurgitation. Although performed in experimen-
tal animal models, these reports suggest that modification of
mitral valve tethering may be a useful adjunct to annular
plication in the treatment of ischemic mitral regurgitation.
PREOPERATIVE RISK STRATIFICATION. In a multicenter
trial to confirm the value of dobutamine stress testing in
preoperative risk stratification in patients with low gradient
(40 mm Hg), but severe, aortic stenosis (aortic valve
resistance 1.0 cm2), it was shown that an increase in
cardiac output by 20% compared with baseline was
associated with a marked decrease in surgical mortality (5%
vs. 32%) and improved postoperative functional recovery.
Predictors of long-term survival were valve replacement and
preoperative contractile reserve (88). Relative aortic stenosis
(an increase in valve area 0.3 cm2, with a final valve area
1 cm2) during dobutamine stress testing was found in only
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5% of patients in this study and in contrast with earlier
reports and was not associated with a good prognosis.
Miscellaneous. In a letter to the editors of the New
England Journal of Medicine, Aepfelbacher, Breen and Man-
ning (89) noted that reports on the safety of transesophageal
echocardiography in more than 25,000 patients and upper
gastrointestinal endoscopy in more than 500,000 patients do
not list methemoglobinemia as a potential complication
(89). Methemoglobinemia results from oxidation of ferrous
iron (Fe 2) to ferric iron Fe, which renders the
hemoglobin molecule unavailable for oxygen transport and
may be triggered by the topical anesthetic used in endo-
scopic procedures. They report two cases experienced in
their laboratory in a three-month period. Methemoglobin-
emia was characterized by a fall in arterial oxygen saturation,
unrelieved by 100% oxygen, and cyanosis. We have also
noted four cases of methemoglobinemia developing during
transesophageal echocardiography procedures in the last
year, all requiring treatment with intravenous methylene
blue (1 to 2 mg/kg given over a 5-min period). Individuals
performing transesophageal echocardiographies, therefore,
should be aware of this underemphasized complication.
Summary. During the past year, progress in echocardiog-
raphy has been reported in many areas with new methods
available to answer increasingly sophisticated clinical and
research questions. As these new techniques mature, exist-
ing methods have and will continue to expand our under-
standing of important clinical issues and further clarify
mechanisms of cardiac disease.
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